Status:

COMPLETED

Feasibility Study of the Reia Vaginal Pessary

Lead Sponsor:

Reia, LLC

Conditions:

Pelvic Organ Prolapse

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to obtain preliminary data on the effectiveness, safety, function, comfort, and patient satisfaction with a novel vaginal pessary design for the use in women who suffer fr...

Detailed Description

The purpose of this study is to evaluate the effectiveness, safety, function, and comfort of a novel vaginal pessary design for the treatment in women who suffer from of pelvic organ prolapse and who ...

Eligibility Criteria

Inclusion

  • Females with Stage II pelvic organ prolapse or greater
  • Users of a Gellhorn or ring style pessary, inclusive of sizes 1.5"-3", for \>3 months' duration
  • Capable of giving informed consent

Exclusion

  • Pregnancy Short vaginal length (total vaginal length \< 8 cm), or subjective vaginal narrowing
  • Deep vaginal erosion noted with removal of current pessary
  • Presence of vesicovaginal fistula
  • Presence of rectovaginal fistula
  • Vaginal, rectal, or bladder tumor
  • Presence of open wound or tear near vagina or anus by exam prior to removal of current pessary
  • Untreated vaginal or urinary infection requiring treatment
  • History of recurrent urinary tract or vaginal infections
  • Inflammatory bowel disease
  • Chronic pain syndromes of pelvic or anorectal origin
  • Previous pelvic floor surgery in last 12 months
  • Congenital malformation of bladder, rectum, or vagina
  • Significant medical condition interfering with study participation (psychologic, neurologic, active drug/alcohol abuse, etc.)
  • Planning pregnancy in next 6 months
  • Previous treatment failure with a pessary

Key Trial Info

Start Date :

November 21 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 16 2023

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT04508335

Start Date

November 21 2021

End Date

June 16 2023

Last Update

November 27 2024

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35233

2

Boston Urogynecology Associates

Cambridge, Massachusetts, United States, 02138

3

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03756

4

New York Medical College

Hawthorne, New York, United States, 10532